GR
Gaingels Revel Pharmaceuticals LLC
SEC filingOther · Burlington, VT
Amount raised$84Ksold at filing
Total offering$84K
Investors in the raise10count reported to the SEC
FiledOct 7, 2025first sale Sep 30, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Paul GrossingerExecutive Officer
Executive officers, directors and promoters as listed on the Form D.